Results 241 to 250 of about 381,122 (317)

Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Huang HB, Zhu YB, Yu DX.
europepmc   +1 more source

Association of time-to-treatment with prognosis in pneumocystis pneumonia among immunocompromised patients without HIV infection: a multi-center, retrospective observational cohort study. [PDF]

BMC Infect Dis
Fujioka H, Matsui H, Homma Y, Nagai T, Otsuki A, Ito H, Ohmura S, Miyamoto T, Shichi D, Tomohisa W, Otsuka Y, Nakashima K.   +11 more
europepmc   +1 more source

Pneumocystis pneumonia

, 2013
openaire   +1 more source

Pneumocystis pneumonia in French intensive care units in 2013-2019: mortality and immunocompromised conditions. [PDF]

Ann Intensive Care
Kamel T, Boulain T.
europepmc   +1 more source

The 2025 EQUAL <i>Pneumocystis</i> Score-an ECMM tool to measure QUALity in <i>Pneumocystis</i> pneumonia management. [PDF]

JAC Antimicrob Resist
Haensel L, Sprute R, Grothe J, Robert-Gangneux F, Gangneux JP, Meis JF, Cornely OA, Koehler P.   +7 more
europepmc   +1 more source

<i>Pneumocystis</i> Pneumonia in a Patient With Colorectal Cancer Receiving Bevacizumab and mFOLFOX6 Therapy. [PDF]

Cancer Diagn Progn
Maki M, Takada R, Nomura N, Chiko Y, Senoo S, Takahashi Y, Saito S, Hamaoka T.   +7 more
europepmc   +1 more source

Effectiveness of pulse methylprednisolone in patients with non-human immunodeficiency virus pneumocystis pneumonia: a multicentre, retrospective registry-based cohort study. [PDF]

BMC Infect Dis
Morimoto Y, Matsui H, Fujioka H, Homma Y, Nagai T, Otsuki A, Ito H, Ohmura SI, Miyamoto T, Shichi D, Watari T, Otsuka Y, Nakashima K.   +12 more
europepmc   +1 more source